RobertP

[RobertP @joropadi]

The Moon in Times of Covid-19
El Salvador, 07 of April 2020
Photo By: Roberto Pacas.

[RobertP @joropadi]

@DavidVanKnapp11 Stock

[RobertP @joropadi]

@ROLEX Awesome!

https://t.co/Og2LjzexGg

[RobertP @joropadi]

@ROLEX https://t.co/Og2LjzexGg

[RobertP @joropadi]

@ITROriginal Si son bonitas….

https://t.co/TwTBt2gdaO

[RobertP @joropadi]

El Porsche 911: 60 años del auto que se negó a morir

https://t.co/rxLWjdj2k5

#porsche911
#porsche
#ingenieria
#speed
@HISTORY
@HistoriaNG
@Porsche
@PorscheRaces @PorscheNewsroom @PorscheCIub @Porsche911UK
@PorscheMexico @PorscheDesign @PorscheJP

[RobertP @joropadi]

@EDHNoticias Triste noticia @EDHNoticias

[Hims & Hers Comms @HimsHersComms]

Coming soon. Let’s do this.

https://t.co/vvej6TNHAL

[Shay Boloor @StockSavvyShay]

$NVO CEO said the partnership with $HIMS is meant to make its products accessible to as many patients as possible.

He also pointed to Hims & Hers’ 2.5M-user platform as a direct way to reach a growing base of patients.

[Hims & Hers Comms @HimsHersComms]

We’re making a strategic shift in our weight loss business to reflect what we believe is the future of the industry, starting with a strategic collaboration with @novonordisk.

Later this month, Hims & Hers customers will have access to Novo Nordisk’s FDA-approved oral and injectable Wegovy® through our platform at self-pay prices. This evolution will make us the largest global consumer health platform providing access to affordable, approved medications.

It’s just the start of what we think is possible when innovators work together to help more people feel great.

More at the link below ⬇️
https://t.co/lGuHuUiOGA

Important info here: https://t.co/glOFq5Mbhi

[Novo Nordisk @novonordisk]

#PRESS: We are expanding US patient access to FDA-approved semaglutide medicines through Hims & Hers in response to a shift in their US GLP-1 business model.

Learn more in the press release here: https://t.co/Jna8BWDPxc

[RobertP @joropadi]

@Steph_iscrypto @grok is this true?

[Hims & Hers Comms @HimsHersComms]

Our track record speaks for itself and is why we’ve been able to help nearly 2.5M customers access care personalized to their needs. We’re focused on bringing more access, more positive outcomes, and more choice to customers everywhere. That’s as true today as it was at our founding.

This is not the first time (nor will it be the last time) a big pharma company has suggested taking an accessible, customer-first approach to healthcare is dangerous, illegal, or bad for the marketplace. This narrative is as predictable as it is outdated and false.

[Hims House @himshouse]

🚨 BREAKING: $HIMS LAUNCHES CANCER DETECTION TESTING

- Hims will offer access to Galleri, a blood test from GRAIL, that screens for 50+ types of cancer
- Hims invested in GRAIL in Oct 2025
- Add-on service at $250 below list price 👀

[The Long Investor @TheLongInvest]

$HIMS

Big

[Brad Garlinghouse @bgarlinghouse]

The last couple of weeks have been an absolute firestorm of action to get the Market Structure bill passed. While @BankingGOP clears its logjam (thank you @SenatorTimScott!), congrats are in order to @SenateAgGOP and Chairman @JohnBoozman for advancing the Senate Agriculture Committee’s market structure bill out of committee today.

As I’ve said before, clarity is better than chaos. The legislative process can be messy and complex, but it is 100% necessary to have clarity for this and future generations of crypto entrepreneurs, builders, and users as this technology becomes increasingly ingrained into our global financial infrastructure.

[RobertP @joropadi]

@WhaleEverything @NoLimitGains @grok DONE

[RobertP @joropadi]

@GrindeOptions Yes

[RobertP @joropadi]

@GrindeOptions Pltr, hims, aapl, goog, brk/b, amzn….

[RobertP @joropadi]

@isabellasg3 I can! Used to play with my grandfather…